Evidence map›Paper›PMID 40756285›Full record

ArticleMicroplastics and nanoplastics2025

Top-down generated micro- and nanoplastics reduce macrophage viability without eliciting a pro-inflammatory response.

Annemijne E T van den Berg, Kas J Adriaans, Luke A Parker, Elena M Höppener, Hanna M Dusza, Juliette Legler, Raymond H H Pieters

Abstract read
In one paragraph

Article in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Annemijne E T van den BergInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 104-106, 3584 CM Utrecht, The Netherlands.
Kas J AdriaansInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 104-106, 3584 CM Utrecht, The Netherlands.
Luke A ParkerTNO Environmental Modelling, Sensing and Analysis, Utrecht, The Netherlands.
Elena M HöppenerTNO Environmental Modelling, Sensing and Analysis, Utrecht, The Netherlands.
Hanna M DuszaInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 104-106, 3584 CM Utrecht, The Netherlands.
Juliette LeglerInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 104-106, 3584 CM Utrecht, The Netherlands.
Raymond H H PietersInstitute for Risk Assessment Sciences, Utrecht University, Yalelaan 104-106, 3584 CM Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of micro- and nanoplastic particles (MNPs) in our environment, food and drinking water has raised public concern due to inevitable human exposure. MNPs can be intentionally added to products or formed from plastics through fragmentation in the environment. Macrophages may become activated upon encountering MNPs, potentially triggering inflammation. However, this process, particularly in response to fragmented MNPs, remains poorly understood. This study aims to investigate whether fragmented MNPs have cytotoxic and pro-inflammatory effects on human macrophages. We examined the immunotoxic effects of mechanically degraded secondary polyvinylchloride, polypropylene and polyamide particles (PVC, PP; < 1 μm and 1-5 μm, PA6.6; 1-5 µm), in addition to primary polystyrene beads (PS; 0.05, 0.2 and 1 μm) and titanium dioxide particles (TiO Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00138-5.

Indexed as

Immune systemMacrophagesMicroplasticsNanoplasticsSecondary microplasticsToxicology

Identifiers

PMID40756285
PMCPMC12316794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.